CSPC pharmaceutical group appoints Qu Zhiyong as executive director

CSPC Pharmaceutical Group Limited has appointed Mr. Qu Zhiyong as an executive director, effective November 21, 2025. Mr. Qu, 44, joined the Group in July 2004 and currently serves as the general manager of the Hong Kong Head Office Management Centre and a director of the Finance Centre, overseeing the Group's financial affairs. He holds a Bachelor's degree in Business Administration from Hefei University of Technology.

Mr. Qu has entered into a three-year service contract, with a monthly salary of RMB60,000 and an annual director's fee of HK$63,000, along with eligibility for performance-related discretionary bonuses. His personal interests include 90,000 shares of the Company, 700,000 unvested share awards granted by Key Honesty Limited, and 800 shares of CSPC Innovation Pharmaceutical Co., Ltd., an indirect non-wholly owned subsidiary.

The board, which now includes Mr. Qu as an executive director alongside others such as chairman Mr. Cai Dong Chen, comprises ten executive directors and six independent non-executive directors.